Tag Archives: Stewart Washer

DayaCann AusCann Group Holdings - Medical Liaison Managers placement Tasmanian Alkaloids and Chilean License

AusCann Welcomes The Passing of Medicinal Cannabis Legislation Amendment

AusCann Welcomes The Passing of Medicinal Cannabis Legislation Amendment

CARABOODA, Western Australia, Oct. 20, 2017 /Weed Wire/ — AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) welcomes the passing of the Medicinal Cannabis Legislation Amendment (Securing Patient Access) Bill 2017 (the Bill) in the Senate yesterday.

DayaCann AusCann Group Holdings - Medical Liaison Managers placement Tasmanian Alkaloids and Chilean License

AusCann: Medical Liason Managers Appointed

CARABOODA, Western Australia, Sept. 14, 2017 /Weed Wire/ — AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) is pleased to announce it has appointed three Medical Liaison Managers (MLMs), to manage doctor communications and assist in the prescription of AusCann’s cannabinoid medicines in Australia.

Zelda Announces Priority Share Offer for CannPal Animal Therapeutics IPO Shares

Zelda Announces Priority Share Offer for CannPal Animal Therapeutics IPO Shares

The Board of Zelda Therapeutics Ltd is pleased to announce that its shareholders are invited to participate as a priority applicant in the prospectus capital raising of CannPal Animal Therapeutics Limited (CannPal) lodged with the ASIC.

Zelda Therapeutics Research Programme Zelda autism Research Collaboration

Zelda Expands Its Breast Cancer Research Collaboration with Complutense University Madrid

PERTH, Australia, July 31, 2017 /Weed Wire/ — The Board of Zelda Therapeutics Ltd (ASX: ZLD, Zelda or the Company) is pleased to announce it has expanded its research collaboration with Complutense University.

DayaCann AusCann Group Holdings - Medical Liaison Managers placement Tasmanian Alkaloids and Chilean License

AusCann – Tasmanian Alkaloids Licences Secured

CARABOODA, Western Australia, July 11, 2017 /Weed Wire/ — AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) is pleased to announce its strategic partner Tasmanian Alkaloids Pty Ltd has been granted a medicinal cannabis licence and a research and development licence from the Office of Drug Control.

AusCann

AusCann Group Provides Quarterly Overview

CARABOODA, Western Australia, April 28, 2017 /Weed Wire/ — AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) has today announced its appendix 4C for the 3 month period ended 31 March 2017 and is pleased to provide an overview of its activities for the quarter.


Top